Table 5 Results of occipital nerve block (ONB) in persistent idiopathic facial pain (FP)
ID | Sides/mixture/volume | Pre-ONB | Post-ONB 3 days | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
Tenderness over GON | Intensity (VAS) | Hypästhesia after ONB | % of pre-ONB pain | Intensity (VAS) | Duration of improvement (days) | Response (≥50%) | Painful? | Side effects? | ||
FP1_1 | 2× (30 mg L; 4 mg D/2.5 ml) | Ipsilateral | 6/10 | Right−, left− | 5 | 1/10 | 11 | + | – | – |
FP1_2 | 2× (30 mg L; 4 mg D/2.5 ml) | None | 4/10 | Right−, left− | 40/100a | 4/10 | 0 | – | – | – |
FP1_3 | 2× (30 mg L; 4 mg D/2.5 ml) | Ipsilateral | 7,5/10 | Right−, left− | 0 | 0/10 | 7§ | + | – | – |
FP1_4 | 2× (50 mg L(1%); 4 mg D/6 ml) | None | 6/10 | Right−, left− | 80% | 5/10 | 0 | – | – | – |
FP2 | 1× (30 mg L; 4 mg D/2.5 ml) | Ipsilateral (unilateral block) | 8/10 | Left− | 100# | 5/10 | 0 | – | – | + |
FP3 | 2× (30 mg L; 4 mg D/2.5 ml) | Ipsilateral contralateral | 3,5/10 | Right−, left− | 100 | 3,5/10 | 0 | – | – | – |
FP4_1 | 2× (30 mg L; 4 mg D/2.5 ml) | Ipsilateral contralateral | 8/10 | Right−, left− | 100 | 8/10 | 0 | – | + | – |
FP4_2 | 2× (50 mg L(1%); 4 mg D/6 ml) | Ipsilateral contralateral | 6/10 | Right+, left+ | 60% | 5/10 | 0 | – | – | – |
FP5 | 2× (50 mg L(1%); 4 mg D/6 ml) | Ipsilateral | 7/10 | Right−, left− | 100 | 7/10 | 0 | – | – | – |